One Family Has Now Given Over $1.1 Billion to Crack the Code on Bipolar Disorder and Schizophrenia. It’s the Largest Private Gift in Psychiatric Research History.

The Stanley Family Foundation announced a $280 million gift to the Broad Institute of MIT and Harvard on March 18, making it one of the largest single donations in the history of psychiatric research — and pushing the family’s total investment in mental health science past $1.1 billion.

The money will fund continued work at the Stanley Center for Psychiatric Research, which brings together more than 100 scientists working across human genetics, neurobiology, stem cell biology, chemistry, and clinical psychiatry. The explicit goal: to accelerate the path from gene discovery to real treatments for bipolar disorder and schizophrenia.

A personal mission

The donation is deeply personal. Ted and Vada Stanley’s commitment to psychiatric research began decades ago when their son Jonathan was diagnosed with severe bipolar disorder while in college. Jonathan manages his condition with the help of lithium — a medication that has been the gold standard for treating bipolar mania for decades — but the Stanleys were struck by how limited treatment options remained for most patients.

That frustration has driven more than 30 years of philanthropy. The family’s previous gifts include a $650 million commitment to the Broad Institute in 2014 — at the time, the largest single investment in psychiatric research ever made. The new gift signals that the Stanleys believe the science is closer than ever to breakthroughs.

What the money will fund

According to the Broad Institute’s announcement, the funding will support several areas of research. The Stanley Center’s work includes large-scale genetic studies — similar to the kind that recently linked 14 psychiatric conditions through shared genetic architecture — as well as efforts to translate those genetic findings into targeted therapies.

The center is also working on stem cell biology to model psychiatric conditions in the lab, computational tools to analyze massive genetic datasets, and clinical collaborations designed to get promising compounds into trials faster.

Why it matters now

The timing is significant. Psychiatric medication development has lagged behind almost every other area of medicine for decades. Most drugs used to treat bipolar disorder today — lithium, valproate, atypical antipsychotics — were either discovered by accident or repurposed from other conditions. The underlying biology of mania and mood instability has remained poorly understood, which has made it difficult to design medications that target the root cause rather than just managing symptoms.

Recent advances in genetics have begun to change that picture. Scientists have identified dozens of genetic variants associated with mania and bipolar disorder, including new pathways that could lead to alternatives to lithium for patients who don’t respond to existing treatments. The Stanley Center’s work is directly connected to these efforts.

The scale of the problem

Bipolar disorder affects an estimated 46 million people worldwide, according to the World Health Organization. In the United States alone, roughly 5.7 million adults live with the condition. Despite its prevalence, federal funding for bipolar disorder research has historically been modest compared to conditions like cancer and heart disease — making private philanthropy like the Stanley gift unusually important.

The $1.1 billion total that the Stanley family has now committed represents a sustained, decades-long investment in a field that has often struggled for both funding and public attention. Whether it ultimately produces the breakthrough treatments the family hopes for remains to be seen, but the sheer scale of the commitment has already reshaped the landscape of psychiatric research.

A note from Jayne Millerton: When I was first diagnosed with bipolar I, the treatment conversation was short — lithium or valproate, pick one. Knowing that a family has bet over a billion dollars on finding something better gives me real hope. Not the vague kind. The kind where scientists are actually in labs working on it right now.

Sources: Boston Globe | Broad Institute

See recent or related posts:
• Largest Genetic Study Ever Links 14 Psychiatric Conditions — Including Bipolar
• How Lithium Keeps Bipolar Mania in Check: New Study Reveals Mechanism
• New Research Points to Lithium Alternative for Treatment-Resistant Bipolar Disorder
• Parts of Brain Shrink After First Manic Episode in Young People
• Your Gut May Be Influencing Your Bipolar Mood Swings